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Introduction
HbA1c is the most important parameter for the evaluation of glycemic control in diabetes and the grounds for establishing a treatment strategy. Its value reflects the past 3-4 months' average blood glucose level. HbA1c is formed through a non-enzymatic glycation pathway by the exposure of hemoglobin to plasma glucose.
Its value is limited in the diagnosis of new cases of diabetes mellitus, due to an interindividual variation depending on multiple factors: age, gender, ethnicity, season (in the cold season the values are higher due to physiological and/or metabolic factors related to temperature), iron levels, smoking, erythrocyte turnover, glycation phenotype, etc.) and the difference between procedures (depending on the method used for the measurement, moreover, several error sources should be avoided). According to research data on Japanese diabetic patients, seasonal fluctuation of HbA1c levels have been observed, with highest levels in March (7.69%) and lowest in August (7.46%; p<0.001) (1) . Multiple factors seem to be involved in the seasonal variation of HbA1c: physical activity and food intake leading to weight changes (peaks were observed after holidays such as Christmas and Easter), exposure to sunlight (in correlation with vitamin D synthesis) depending on weather patterns. A study carried out in Greece showed significant differences between the highest HbA1c values (in March) and lowest (in September) (2) . In a study performed on type 2 diabetic subjects with ages ranging between 26-94 years researchers concluded that serum vitamin D levels were inversely associated with HbA1c levels (r=−0.116, p=0.003). This relation maintains its independence in the multivariate analysis after adjusting for age, sex, HbA1c, body mass index, treatment and duration of diabetes and nephropathy (3) .
The value of HbA1c increases with age (4). The erythrocytes of patients with iron deficiency anemia have a longer lifetime, as such, they might have higher HbA1c values (5) . Smoking increases HbA1c value in type 1 and 2 diabetic patients (6) . Teenage girls have significantly higher HbA1c values compared to boys of the same age (7) .
As hemodialysis increases the number of young erythrocytes as a consequence of the treatment with erythropoietin, the HbA1c values will be artefactually lower (8 Our purpose was to describe the advantages and disadvantages of the different methods, and to analyze the effect of some error sources on the HbA1c results, revealing the problems that could occur in assays with less resolution. Additionally, we studied the correlation between the results obtained using the Variant I analyzer and those given by the Biomidi reagent kit, Micromat II and In2it.
Material and methods
Equipments and sampling:
We used the Variant I, Micromat II, In2it (Bio-Rad) analyzers, and a manual method using the Biomidi reagent kit. Blood samples were collected during November 2010 -March 2012 on K 2 EDTA and stored at 2-8°C. The majority of the patients (71%) were admitted to the Diabetology Compartment of the Emergency County Clinical Hospital in Tîrgu Mures, others (29%) were outpatients from the Marmed medical unit. The age of the patients was between 18-87 years, 8% of them were type 1 diabetic subjects, the rest had type 2 diabetes. Many of them having been diagnosed over 5 years prior to our study. 2580 samples were analyzed using the Variant I equipment, 155 using the BIOMIDI kit and a StatFax photometer. 584 samples were analyzed using the semiautomatic Micromat II (BioRad) method at the Marmed Laboratory in Tîrgu Mureş, 465 samples were processed by the new generation of the Micromat II called In2it (automatic analyzer). The largest number of patient samples were processed on the Variant I, this analyzer being located in the Central Laboratory of the Emergency County Clinical Hospital in Tîrgu Mures.
We evaluated the advantages and disadvantages of these methods, the possible error sources working on samples from diabetic patients (effect of storage at different temperatures, presence of elevated HbF) and Lyphochek control blood (effect of dilution), and the correlation of the results obtained using different methods. The measurements of the compared four equipment were made in different time ranges, so not the same samples had been processed on all the analyzers. Results obtained by the BIOMIDI kit and those on the small capacity point-of-care equipment (Micromat II and In2it) were compared to the reference method (HPLC) using the Variant I analyzer.
Performance of the studied methods
According to the data provided by the Instruction Manual of each equipment, we could compare the performance of the studied analyzers. The mentioned document reveals that the Micromat II has a precision of 4.65% using normal control values (mean: 5.2%), and 2.93% using high control values (mean: 9.48%). These results were obtained during 20 days by one operator using the same instrument and a single batch of reagents using the MicroSafe pipette included in the kit. The manual also mentions the fact that data generated by more than one operator, using multiple instruments and multiple lots of reagents, may have a higher coefficient of variation (CV). The Micromat II system gives a linear response between 4-15% HbA1c using patient samples, and the theoretical performance of the test indicates a linear range of 2 to >25% HbA1c values (12) .
According to the data provided by the manufacturer, the In2it analyzer showed a CV of 2.9% in case of normal HbA1c values (mean: 5.3%), CV was 3.1% in case of slightly elevated HbA1c values (mean: 8.9%), and it was 2.8% in case of very high HbA1c values (mean: 12.0%) using three different batches of test cartridges (13) .
Based on the data in the Instruction Manual, the Variant I system shows a better total precision compared to the previous two point-of-care analyzers, the CV is 2.08% for normal patient values, and 1.67% for diabetic values. Linearity is good up to HbA1c values of 17.9% (14) .
Effect of improper sample dilution on the HbA1c value:
We studied the effect of improper sample dilution on the HbA1c results using the Micromat II and Variant I analyzers, because the plastic pipetting devices of these equipment is predisposed to certain errors. In case of the automatic In2it analyzer, improper sample dilution is not an issue, because the hard plastic pipetting device aspirates the exact amount of required blood, the tip of the device is introduced directly into the cartridge.
In the case of Variant I, when pipetting the first few blood samples with the device, we observed that the aspirated volume was not the required 5 µl, which corresponds to the 1/200 dilution with the 1000 µl hemolysis reagent. It is important to know if these samples should be processed for the HbA1c measurement or the pipetting should be repeated for them. We stu died the effect of improper dilutions (in the range between 1/100-1/400) on the result of HbA1c measurement.
In case of the Micromat II analyzer, we tested the following improper blood volumes: 6, 7, 8, 9, 11, 12 µl.
Sample volume, storage and costs:
In the case of Variant I, the standard dilution of the blood collected on K 2 EDTA is 1/200. Five μl venous blood is required. Blood samples can be stored for up to 7 days at 2-8°C. The cost of a test is around 22 RON.
For the BIOMIDI kit, a manual chromatographic method, 50 ml of blood is required, absorbances are read at 415 nm at the photometer, the percentage of HbA1c is determined compared to total hemoglobin. Statistical analysis was performed by the GraphPad InStat program -Pearson correlationand data were processed using Microsoft Excel. The level of significance was set to p below 0.05.
Results
Correlation between the results obtained by different methods:
Fifty-five samples were processed by the manual chromatographic method and by the Variant I analyzer. Thirty-nine of these samples (having elevated HbF) were selected and processed also with the BIOMIDI reagent kit. We observed a good correlation between values obtained using the Variant I analyzer and the BIOMIDI reagent kit (r = 0.9654, p<0.05), except for some cases of elevated HbF (found in case of 2% of the studied population), because in case of the manual method, HbF and HbA1b fraction (where glycated HbF might be present) coelute with the HbA1c fraction, leading to falsely elevated results (Figure 1) .
In patients having elevated HbF values, the HbA1c results obtained on the BIOMIDI system were the sum of the percentages of the mentioned peaks on the Variant I analyzer (HbA1c+HbF+HbA1b).
In the 35 samples analyzed by the Micromat II analyzer and the Variant I method, we observed good correlation (r = 0.9738, p<0.05). We noted that the results obtained by Variant I were slightly higher, with an average of 0.52%. This is clinically significant according to NACB guidelines.
We performed HbA1c testing of 27 samples using the In2it and Variant I analyzers. Positive correlation of the results could be observed (r=0.9763, p<0.05). 
Effect of improper sample dilution, incorrect storage and handling on the results of the HbA1c measurement
In case of Variant I, too intense shaking (prolonged and energetic shaking instead of mild homogenization) leads to degradation products forming separated peaks. Storage at -20°C causes unknown peaks on the chromatogram, and the results are considerably lower than the real values. Storage at -70°C caused hemolysis, but the blood was well-preserved, the obtained results were very close to the initial values (under 0.5% difference). In case of improper storage at room temperature for 24 h, the measured HbA1c results presented 3% deviation from the actual values obtained using the Variant I analyzer.
The influence of improper sample dilution on the HbA1c results obtained can be observed in Table 2 (Variant I) and Table 3 (Micromat II).
The Micromat II analyzer displayed the "ERROR" message when using 12 µl or more blood.
In case of improper storage at room temperature for 24-h, the Micromat II equipment showed 5.3% decrease in the HbA1c results and 20% decrease after 48-h compared to the actual values.
The results of the HbA1c measurement presented 5.6% deviation from the actual values after 24 h at room temperature using the In2it analyzer, and 7.5% after 48 h.
Discussion
Advantages and disadvantages of the methods:
Variant system Variant I has the capacity of 100 samples/run, it also has Stat position for emergency samples, and requires 7-8 minutes/sample. Chromatographic cartridge, primer, calibrator, control blood are necessary, and an autodilutor is attached to the analyzer pipetting 5µl of blood. The preparation of the samples using the autodilutor system is time consuming for the operator, samples and controls are diluted to 1:200. A printer and a small screen are included in the analyzer, a series of buttons are used for settings; buffer 1, 2, wash and hemolysis/dilution solution are used.
Small capacity equipment and methods
At smaller sample number the automated chromatography analyzer In2it has several Micromat II needs manual introduction of each solution, it is also rather expensive, but an advantage is that a calibrator cartridge is used, which has a long shelf life. The sample storage conditions and the precision of pipetting influence the results. The plastic pipetting device of Micromat II is predisposed to certain errors especially because of blood excess, while in the case of In2it the device has been improved, being more precise in pipetting 10 µl blood. Micromat II has been gradually replaced by the In2it analyzer on the market.
The manual column chromatography assay using the Biomidi reagent kit is not accurate enough, the columns cannot sufficiently distinguish between the different forms of hemoglobin, and it requires long processing time (2 hours for a sample).
In 2% of the samples processed in Tîrgu Mureș we found persistent HbF (higher than 1.8%) in non-pregnant patients. This might be the explanation for obtaining unexpectedly high HbA1c values in some cases using the manual chromatographic method, before the Variant I was available in this town.
We observed that in case of persistent HbF, the HbA1b peak is also elevated, and these two fractions coelute with HbA1c in methods with less resolution than HPLC.
Some hemoglobin variants can coelute with the HbA1c fraction even on HPLC, for ex. Hb Camden or Hb Wayne, leading to falsely elevated HbA1c values (15) .
In some cases (ex. in homozygous HbE), the percentage of HbA can be so small that HbA1c does not appear on the chromatogram as a peak.
The accuracy of HbA1c measurement is very important in diabetic patients, therapeutic decision is made based on its value, and it is frequently used nowadays for the diagnosis of new cases. To evaluate HbA1c in populations with a high prevalence of hemoglobinopathies, we should use the HPLC method, which is easy to perform, economical, and reliable. Based on an algorithm, hemoglobin variants visualized on HPLC should be reported to the physician to improve the management of patients (16, 17) .
A study comparing 23 HbA1c assays sustains that HbE and HbD-Punjab are the second and fourth most common Hb variants worldwide, thus, the scientists investigated the accuracy of HbA1c measurement in the presence of HbE and/or HbD-Punjab traits. Of the evaluated 23 HbA1c measurement procedures, 9 were immunoassay methods, 10 were ionexchange HPLC methods, and 4 were capillary electrophoresis, affinity chromatography, or enzymatic methods. Statistically significant differences were found in more than half of the methods tested. Only 22% and 13% showed clinically significant interference for HbE and HbD traits, respectively. As a conclusion of this study, some current HbA1c methods show clinically significant interferences with samples containing HbE or HbD traits. To avoid reporting inaccurate results, ion-exchange chromatograms must be carefully examined to identify possible interference from these Hb variants (18) .
Other point-of-care HbA1c measurement systems can be used in case of small number of samples, such as Nycocard Reader II, having very limited situations of error messages obtained especially in case of severe anemia. In case of larger sample numbers, photometric procedures are widely used nowadays instead of chromatographic procedures.
Our study presents some limitations. Some parameters of performance in case of the analyzers (precision, linearity) are presented based on information provided by the manufacturer. No data are available regarding comparison of the HbA1c results obtained on all analyzers or on different point-of-care equipment, each of them only being compared to the best available HPLC analyzer in the area (Variant I), this being the reference method for this measurement. Outpatient samples were analyzed during different periods using the available equipment in the Marmed Laboratory.
Conclusions
The most appropriate methods for HbA1c testing are the automated chromatographic procedures because pipetting errors are minimized and do not require multiple stages of intervention from the laboratory personnel.
There is a positive correlation between the values obtained by different methods, except for the samples with elevated hemoglobin F.
Our study revealed that inappropriate handling or storage of the samples can lead to falsely higher or lower values of the HbA1c measurement.
